Cesar Calderon's Contact Details

Cesar Calderon's Company Details

BTC Network

Quincy, MA, US • 100 - 249 Employees
Major Drugs

Based on increased demands from BlueTheory's over 30 aligned pharmaceutical and CRO strategic partners, BlueTheory has enhanced its site business model and is announcing its rebrand to BTC Network. BTC Network has optimized its infrastructure to an owned and affiliated research site model. The BTC Network team has completed over 300 clinical research studies across a range of therapeutic indications with the goal of expediting study start-up and enrollment while ensuring our research sites provide excellent clinical oversight and good quality data. Today, BTC Network has grown to represent 63 full service, multi-specialty clinical research sites across the United States and Canada. BTC Network is currently in the final stages of acquiring two additional clinical research sites with other acquisitions on the near horizon. BTC Network works on behalf of leading pharmaceutical companies and CROs to excel in the identification, recruitment, and retention of patients. BTC Network's number one focus is patient centricity. By working with BTC Network, sponsors and CROs have access to a fully integrated network of high performing and experienced sites with strong research infrastructures and access to large clinic populations, expediting enrollment. Through the new BTC Network, sponsors will have access to: One central point of contact for trial duration Reporting on any deviations or patient enrollment challenges Clinic and research patient databases of over 500,000 patients across North America Centralized recruitment strategies and our ability to allocate resources as needed One contract and budget for all sites BTC Network's partnerships throughout the industry and streamlined processes from study start-up to close-out will lead to more cost-effective, yet higher quality, research studies for the industry. To stay updated with BTC Network, please like us on Facebook or Twitter!